Scheduled Maintenance Notice

Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.

Select Publications

Preprints

Hogan AB; Wu SL; Toor J; Mesa DO; Doohan P; Watson OJ; Winskill P; Charles G; Barnsley G; Riley EM; Khoury DS; Ferguson NM; Ghani AC, Long term vaccination strategies to mitigate the impact of SARS-CoV-2 transmission: a modelling study, http://dx.doi.org/10.1101/2023.02.09.23285743

Stadler E; Burgess MT; Schlub TE; Chai KL; McQuilten ZK; Wood EM; Polizzotto MN; Kent SJ; Cromer D; Davenport MP; Khoury DS, Monoclonal antibody levels and protection from COVID-19, http://dx.doi.org/10.1101/2022.11.22.22282199

Goel RR; Painter MM; Apostolidis SA; Mathew D; Meng W; Rosenfeld AM; Lundgreen KA; Reynaldi A; Khoury DS; Pattekar A; Gouma S; Kuri-Cervantes L; Hicks P; Dysinger S; Hicks A; Sharma H; Herring S; Korte S; Baxter AE; Oldridge DA; Giles JR; Weirick ME; McAllister CM; Awofolaju M; Tanenbaum N; Drapeau EM; Dougherty J; Long S; D’Andrea K; Hamilton JT; McLaughlin M; Williams JC; Adamski S; Kuthuru O; Unit TUCP; Frank I; Betts MR; Vella LA; Grifoni A; Weiskopf D; Sette A; Hensley SE; Davenport MP; Bates P; Prak ETL; Greenplate AR; Wherry EJ, mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern, http://dx.doi.org/10.1101/2021.08.23.457229

Cromer D; Steain M; Reynaldi A; Schlub TE; Sasson SC; Kent SJ; Khoury DS; Davenport MP, Neutralising antibodies predict protection from severe COVID-19, http://dx.doi.org/10.1101/2022.06.09.22275942

Berry MT; MacIntyre CR; Cromer D; Hacker A; Davenport MP; Khoury DS, Optimal deployment of limited vaccine supplies to combat mpox, http://dx.doi.org/10.1101/2024.11.03.24316551

Ashley CL; Bloul M; Alca S; Smith L; Jin W; Khoury D; Counoupas C; Davenport M; Triccas JA; Steain M, Optimisation of a multiplexed, high throughput assay to measure neutralising antibodies against SARS-CoV-2 variants, http://dx.doi.org/10.1101/2024.09.01.610733

Cromer D; Reynaldi A; Hie A; Schlub TE; Juno JA; Wheatley AK; Kent SJ; Khoury DS; Davenport MP, Predicting COVID-19 booster immunogenicity against future SARS-CoV-2 variants and the benefits of vaccine updates, http://dx.doi.org/10.1101/2024.02.08.24302032

Khoury DS; Docken SS; Subbarao K; Kent SJ; Davenport MP; Cromer D, Predicting the efficacy of variant-modified COVID-19 vaccine boosters, http://dx.doi.org/10.1101/2022.08.25.22279237

Berry MT; Khan SR; Schlub TE; Notaras A; Kunasekaran M; Grulich AE; MacIntyre CR; Davenport MP; Khoury DS, Predicting vaccine effectiveness in Mpox, http://dx.doi.org/10.1101/2023.11.23.23298850

Hogan AB; Mitchell A; Stadler E; Chung Y; Reynaldi A; Elias KM; Docken S; Khoury DS; Schlub T; Davenport MP; Cromer D, Quantifying the association between neutralising antibodies and protection from RSV disease in infants and adults: A systematic review and meta-analysis, http://dx.doi.org/10.64898/2026.02.13.26346212

Koutsakos M; Reynaldi A; Lee WS; Nguyen J; Amarasena T; Taiaroa G; Kinsella P; Liew KC; Tran T; Kent HE; Tan H-X; Rowntree LC; Nguyen THO; Thomas PG; Kedzierska K; Petersen J; Rossjohn J; Williamson DA; Khoury D; Davenport MP; Kent SJ; Wheatley AK; Juno JA, Rapid recall and de novo T cell responses during SARS-CoV-2 breakthrough infection, http://dx.doi.org/10.1101/2022.12.19.521129

Cromer D; Reynaldi A; Steain M; Triccas JA; Davenport MP; Khoury DS, Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial, http://dx.doi.org/10.1101/2021.06.29.21259504

Stadler E; Cromer D; Mehra S; Adekunle AI; Flegg JA; Anstey NM; Watson JA; Chu CS; Mueller I; Robinson LJ; Schlub TE; Davenport MP; Khoury DS, Risk of Plasmodium vivax recurrences follows a 30-70 rule and indicates relapse heterogeneity in the population, http://dx.doi.org/10.1101/2022.05.18.22275180

Williams CG; Moreira ML; Asatsuma T; Skinner OP; Lee HJ; Li S; Barrera I; Murray E; Soon MSF; Engel JA; Khoury DS; Asad S; Steiner TM; Joseph R; Alexandre Y; Mueller SN; Chen F; Haque A, Spatial transcriptomics maps molecular and cellular requirements for CD4+ T cell-dependent immunity to malaria, http://dx.doi.org/10.1101/2023.02.23.529309

Lansink LIM; Engel JA; Lee HJ; Soon MSF; Williams CG; SheelaNair A; Pernold CPS; Laohamonthonkul P; Akter J; Stoll T; Hill MM; Talman AM; Russell A; Lawniczak M; Davenport MP; Khoury DS; Haque A, Systemic host inflammation induces stage-specific transcriptomic modification and slower maturation in malaria parasites, http://dx.doi.org/10.1101/2021.08.18.456784

Skinner OP; Asad S; Moreira ML; Lee HJ; Williams CG; Ruan Z; Lim J; Kerr AS; Li S; Zhu C; Jin W; Steiner TM; Asatsuma T; Wanrooy BJ; Liu Z; Tong MZW; Soon MSF; Engel JA; Shobhana K; Uldrich AP; Khoury DS; Tuong ZK; King HW; Haque A, Temporally overlapping mechanisms diversify clonal B cell responses in vivo, http://dx.doi.org/10.1101/2024.12.17.628863

Hogan AB; Wu SL; Doohan P; Watson OJ; Winskill P; Charles G; Barnsley G; Riley EM; Khoury DS; Ferguson NM; Ghani AC, The value of vaccine booster doses to mitigate the global impact of the Omicron SARS-CoV-2 variant, http://dx.doi.org/10.1101/2022.01.17.22269222

Elias KM; Khan SR; Stadler E; Schlub TE; Cromer D; Polizzotto MN; Kent SJ; Turner T; Davenport MP; Khoury DS, Viral clearance as a surrogate of clinical efficacy for COVID-19 therapies in outpatients: A systematic review and meta-analysis, http://dx.doi.org/10.1101/2023.06.18.23291566


Back to profile page